Published in Nucleic Acids Res on August 11, 2016
Large-scale design of robust genetic circuits with multiple inputs and outputs for mammalian cells. Nat Biotechnol (2017) 0.85
Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease. Gerontology (2016) 0.75
CRISPR-cas Adaptive Immunity and the Three Rs. Biosci Rep (2017) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Studies on transformation of Escherichia coli with plasmids. J Mol Biol (1983) 116.81
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA-guided human genome engineering via Cas9. Science (2013) 48.29
A TALE nuclease architecture for efficient genome editing. Nat Biotechnol (2010) 26.47
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 18.01
Altering the genome by homologous recombination. Science (1989) 12.73
Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science (2014) 10.43
Ensembl 2015. Nucleic Acids Res (2014) 8.30
Progress and prospects: zinc-finger nucleases as gene therapy agents. Gene Ther (2008) 7.28
TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol (2012) 7.01
High frequency targeting of genes to specific sites in the mammalian genome. Cell (1986) 6.91
A transcription activator-like effector toolbox for genome engineering. Nat Protoc (2012) 6.81
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System. Cell (2015) 5.97
Regulation of DNA repair throughout the cell cycle. Nat Rev Mol Cell Biol (2008) 5.10
Quantitation of targets for PCR by use of limiting dilution. Biotechniques (1992) 4.65
Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods (2013) 4.61
Controlled expression of transgenes introduced by in vivo electroporation. Proc Natl Acad Sci U S A (2007) 4.57
Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol (2014) 4.41
Regulation of homologous recombination in eukaryotes. Annu Rev Genet (2010) 4.33
Mechanisms of site-specific recombination. Annu Rev Biochem (2006) 4.29
Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol Cell Biol (1995) 3.96
Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature (2015) 3.77
Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol (2014) 3.72
Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol (2015) 3.64
DNA inversions in the chromosome of Escherichia coli and in bacteriophage Mu: relationship to other site-specific recombination systems. Proc Natl Acad Sci U S A (1983) 3.46
Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol (2001) 3.39
Mammalian genomes contain active recombinase recognition sites. Gene (2000) 3.08
Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol (2015) 2.77
Circular polymerase extension cloning of complex gene libraries and pathways. PLoS One (2009) 2.74
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. Elife (2014) 2.65
A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet (2002) 2.02
Synthesis of programmable integrases. Proc Natl Acad Sci U S A (2009) 1.94
Alteration of Cre recombinase site specificity by substrate-linked protein evolution. Nat Biotechnol (2001) 1.92
j5 DNA assembly design automation software. ACS Synth Biol (2011) 1.78
Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer (2011) 1.67
Sequence determinants of improved CRISPR sgRNA design. Genome Res (2015) 1.56
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol (2015) 1.41
The DNA invertase Gin of phage Mu: formation of a covalent complex with DNA via a phosphoserine at amino acid position 9. EMBO J (1988) 1.41
Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges. J Mol Biol (2011) 1.38
Chimeric TALE recombinases with programmable DNA sequence specificity. Nucleic Acids Res (2012) 1.38
Chimeric recombinases with designed DNA sequence recognition. Proc Natl Acad Sci U S A (2003) 1.35
Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res (2001) 1.34
Structure-guided reprogramming of serine recombinase DNA sequence specificity. Proc Natl Acad Sci U S A (2010) 1.31
Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): A new phenotype. Mov Disord (2006) 1.29
Evolution of programmable zinc finger-recombinases with activity in human cells. J Mol Biol (2007) 1.28
Directed evolution of recombinase specificity by split gene reassembly. Nucleic Acids Res (2010) 1.19
Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase. Nucleic Acids Res (2011) 1.13
Site-specific recombination in bacteriophage Mu: characterization of binding sites for the DNA invertase Gin. EMBO J (1988) 1.12
Recombinase-mediated cassette exchange (RMCE) - a rapidly-expanding toolbox for targeted genomic modifications. Gene (2012) 1.11
The influence of DNA double-strand break structure on end-joining in human cells. Nucleic Acids Res (2001) 1.09
A comprehensive approach to zinc-finger recombinase customization enables genomic targeting in human cells. Nucleic Acids Res (2013) 1.04
New mammalian cellular systems to study mutations introduced at the break site by non-homologous end-joining. DNA Repair (Amst) (2005) 1.02
Managing meiotic recombination in plant breeding. Trends Plant Sci (2008) 0.95
Expanding the scope of site-specific recombinases for genetic and metabolic engineering. Biotechnol Bioeng (2013) 0.92
Repair at single targeted DNA double-strand breaks in pluripotent and differentiated human cells. PLoS One (2011) 0.91
Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity. Nat Biotechnol (2016) 0.90
A new variable phenotype in spinocerebellar ataxia 27 (SCA 27) caused by a deletion in the FGF14 gene. Eur J Paediatr Neurol (2013) 0.87
Zinc-finger recombinase activities in vitro. Nucleic Acids Res (2011) 0.84
Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study. Genet Epidemiol (2014) 0.82
Expanding the zinc-finger recombinase repertoire: directed evolution and mutational analysis of serine recombinase specificity determinants. Nucleic Acids Res (2014) 0.81
Enhancing the specificity of recombinase-mediated genome engineering through dimer interface redesign. J Am Chem Soc (2014) 0.81
Target-specific variants of Flp recombinase mediate genome engineering reactions in mammalian cells. FEBS J (2015) 0.79
A novel frameshift mutation in FGF14 causes an autosomal dominant episodic ataxia. Neurogenetics (2015) 0.79
Spinocerebellar ataxias type 27 derived from a disruption of the fibroblast growth factor 14 gene with mimicking phenotype of paroxysmal non-kinesigenic dyskinesia. Brain Dev (2011) 0.77
Long-term and efficient expression of human β-globin gene in a hematopoietic cell line using a new site-specific integrating non-viral system. Gene Ther (2015) 0.77
Editing Plant Genomes: a new era of crop improvement. Plant Biotechnol J (2016) 0.77
Fidelity of end joining in mammalian episomes and the impact of Metnase on joint processing. BMC Mol Biol (2014) 0.77
Isolation and quantification of episomal expression vectors in human T cells. Biotechniques (1997) 0.76